Home / About

Market Outlook

Forward-looking analysis on refractive lens exchange and ophthalmology — with every figure labeled as observed data, an estimate, a forecast, or editorial interpretation.
How rankings work here: every ranking on this page publishes its full scoring methodology alongside the result. We don’t rank individual providers or companies — only geographic and procedure-level comparisons built from the same statistics and datasets published elsewhere on this site. See Methodology for the scoring framework behind each list.
U.S. RLE Market: 2027–2029 Volume Forecast

Projects continued procedure volume growth through 2029, built on the observed 2016–2026 trend and current premium lens adoption trajectory.

Will Light-Adjustable Lenses Become the Default Premium Option?

Examines current LAL adoption trajectory against manufacturer pipeline data, with our editorial view on likely inflection points.

Where RLE Pricing Is Headed Through 2027

Extends the Cost Index trend forward, distinguishing premium-category price pressure from broader healthcare cost inflation.

EVO ICL’s Ceiling: How Large Can the Category Get?

Estimates total addressable patient population for EVO ICL against current adoption rates, with editorial commentary on structural limits to growth.

Secret Link

Search data